
They find it soooo easy to earn your money. Nobody said the company is bad or no good. So many other factors. Macro economic conditions, market timing, sector performance, PE ratio and of course, the crouching tiger hidden dragon we all know about some analyst.
Think about this for once. Everytime you think there is certain value in a stock and you buy, why are there others who find the stock too expensive and sells to you.
Food for thought.
p_for_profit ( Date: 09-Nov-2012 18:31) Posted:
|
Obviously good profits/results and analyst reports are not the only factors but they are both are among top 3 reasons why people buy stock.
I am willing to be patient and wait for the market to correct but considering Biosensor fundamentals and results, it's so obvious that it is worth more (atleast to me). 
Just want to see if anyone can shine more light on possible reasons.
There are so many factors that can influence a stock's price. Good Q results and analyst's report are just some of them. They are NOT thr only factors. If they are, there will be no low wage workers like cleaners or garbage collectors. Everybody will know exactly when and where to put their money. Everybody will be rich and making more and more money as nobody needs to cut loss.
Don't be frog in a well. Investing and trading needs knowledge and patience.
p_for_profit ( Date: 09-Nov-2012 17:09) Posted:
|
p_for_profit ( Date: 09-Nov-2012 17:09) Posted:
|
LOL!! 


It's rather amazed how  resilience STI is. What I want to see,  bull shitting heavily on it's pant...until the pants burst .......
chartreader ( Date: 09-Nov-2012 17:11) Posted:
|
well, it hasnt broken the important 1.10 support yet should be ok.
next support at 1.07. 
am not vest. i sold it when it broke 1.10 (my cut loss) previously and fell as low as 1.02. 
am not back in yet. company buyback is a good sign though. but with all med stocks, prepare to hold mid-long term la. last few days decline just mirrored the general sentiments. don't think there s real cause for alarm.
I am very confused with this counter!! doesnt make any sense
1) Almost every house has TP above 1.6. Even if they are terribly wrong, fair value is definitely more than 1.25 atleast
2) Even after one of the best ever result this quarter the price has stagnated today.
3) When the company is buying back at 1.1 today close at 1.095
Is this totally random?? or something more insightful happening here? Any expert comments here?
 
Vested with 9 Lots. Believe in mid to long term biosensor can reach 1.4 atleast.
raykee ( Date: 09-Nov-2012 15:32) Posted:
|
xin9999 ( Date: 09-Nov-2012 15:17) Posted:
|
xin9999 ( Date: 09-Nov-2012 15:17) Posted:
|
Although the amount is relatively small at 1.5m shares (just 0.09% of its total shares outstanding), we believe this sends a positive signal to investors and could set a precedent for future share buybacks.
The share buyback also makes a lot of sense, in our view, given BIG’s large net cash position of US$331.7m (as at 30 Sep 2012). It would also provide BIG with more flexibility as compared to paying out dividends since we believe that BIG is a growth company and would likely reinvest most of its proceeds into growing its business.
Maintain BUY and fair value estimate of S$1.69
From the Edge, today...........
CIMB Research cut its target price for medical device maker Biosensors International Group to $1.79 from $1.82 and kept its ‘outperform’ rating, citing risks of weaker licensing income from Japan and potential price cuts in other countries.
Biosensors shares were down 1.3% at $1.125, and have plunged 21% since the start of the year, compared with the 26% rise in the FTSE ST Mid Cap Index.
Biosensors said on Wednesday its second-quarter net profit rose 22.7% to $28.2 million from a year earlier, helped by higher product revenue.
The brokerage cut its earnings estimates for Biosensors for 2013, but noted that its product profitability remains strong and valuations are at an attractive low level.
CIMB said Terumo Corp, which licenses Biosensors’ drug-eluting stent technology for a royalty fee, has stated that it will be fighting to claw back market share lost, which should offer respite to Biosensors’ licensing revenue.
Biosensors maintained its expectations that 2013 revenue will grow at 20-30%, as a royalty agreement negotiated with Terumo should offset competition and any mandatory price cut, CIMB said
THANK YOU for the news! Good job Bios, to buy back shares at $1.11,  shows company is confident abt their prospects and boost sentiment towards the share too.  Recall  Wilmar buying back their own shares at $3?  wow,  that had  provided a floor since. 
This wil be a multi bagger  once good sentiment returns to the mkts. Up up and away.
 
starlene ( Date: 08-Nov-2012 20:35) Posted:
|
hudson222 ( Date: 08-Nov-2012 20:24) Posted:
|
Secure Financial Instruments from a Direct and Genuine Provider of SBLC, BG, MTN, LC for lease directly from any top banks, HSBC London, Deutsche Bank, Barclays Bank etc.
 
We also have excellent seller sources for cash backed Medium Term Notes (MTNs]
 
To Finance Businesses all over the world.
 
Allan Hudson
Telephone: +44 740 5581450
Email: financeprov1@gmail.com
U.K
http://www.sgx.com/wps/portal/sgxweb/home/company_disclosure
 
all shortists are welcome to short Biosensor...see how they scurried like mice tomorrow with this news(latest 6.50pm-today)
infancybird ( Date: 08-Nov-2012 19:13) Posted:
|